Core Viewpoint - FendX Technologies Inc. has completed debt settlements to improve its financial position by reducing existing liabilities, issuing shares and units to settle a total of $629,338.20 in debt [1][3][4] Debt Settlements - The company issued 1,249,024 common shares at $0.082 per share to settle $102,420 of debt [1] - Additionally, 8,781,969 units were issued at $0.06 per unit to settle $526,918.20 of debt, with each unit consisting of one share and one transferable warrant [1][2] - The warrants allow holders to acquire additional shares at $0.10 for 36 months, with potential acceleration of expiry if share prices exceed $0.20 for 20 consecutive trading days [2] Financial Position Improvement - The debt settlements are aimed at enhancing the company's financial health by reducing liabilities [3] - The securities issued are subject to a hold period of four months and one day from the issuance date [3] Related Party Transactions - Two insiders participated in the debt settlements, settling a total of $435,043.20 in debt, classified as related party transactions [4] - The company is relying on exemptions from formal valuation and minority approval requirements due to the fair market value of the settlements being less than 25% of its market capitalization [4] Product Development - FendX is developing REPELWRAP™ film, a protective surface coating that reduces pathogen adhesion by over 98%, with potential applications in healthcare and other industries [6][7] - The company is also advancing an eco-friendly smart sponge and specialized catheter coatings, holding exclusive agreements and licenses for its technologies [7]